Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00
Provider: Wright Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Marimekko Oyj's President and CEO Takes Sick Leave


Tuesday, 6 Aug 2013 06:00am EDT 

Marimekko Oyj announced that the Company’s President and Chief Executive Officer Mika Ihamuotila underwent a minor repeat neurosurgical procedure in 2011. The post-operative symptoms associated with such procedures sometimes include epileptic symptoms which are treated with regular preventive medication. As of August 6, 2013, Mr. Ihamuotila will be on sick leave for the period of adjustment to his anti-epileptic medication. The leave is estimated to last for approximately four to six weeks. During this time, the duties of President will be taken over by the Company’s Chief Financial Officer Thomas Ekstrom, while Mr. Ihamuotila will participate in the Company’s decision-making part-time. 

Company Quote

8.98
-0.02 -0.22%
4:43am EST